Lysostaphin: model for a specific enzymatic approach to infectious disease

Prog Drug Res. 1972;16:309-33. doi: 10.1007/978-3-0348-7081-8_7.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Bacteriolysis / drug effects
  • Coagulase
  • Dogs
  • Endocarditis, Bacterial / drug therapy
  • Humans
  • Lethal Dose 50
  • Lysostaphin* / biosynthesis
  • Lysostaphin* / pharmacology
  • Lysostaphin* / therapeutic use
  • Lysostaphin* / toxicity
  • Mice
  • Microbial Sensitivity Tests
  • Nose Diseases / drug therapy
  • Nose Diseases / immunology
  • Oxacillin / pharmacology
  • Penicillin G / pharmacology
  • Penicillin Resistance
  • Rabbits
  • Rats
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / immunology
  • Staphylococcus / drug effects
  • Staphylococcus / enzymology
  • Staphylococcus / metabolism
  • Staphylococcus Phages / drug effects

Substances

  • Coagulase
  • Lysostaphin
  • Penicillin G
  • Oxacillin